Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Familial Risk Of Cancer: Data For Clinical Counseling And Cancer Genetics

K. Hemminki, X. Li, K. Czene
Published 2004 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Familial risks for cancer are important for clinical counseling and understanding cancer etiology. Medically verified data on familial risks have not been available for all types of cancer. The nationwide Swedish Family‐Cancer Database includes all Swedes born in 1932 and later (0–to 68‐year‐old offspring) with their parents, totaling over 10.2 million individuals. Cancer cases were retrieved from the Swedish Cancer Registry up to year 2000. Standardized incidence ratios (SIR) and 95% confidence limits (CI) were calculated for age‐specific familial risk in offspring by an exact proband status. The familial risks for offspring cancer were increased at 24/25 sites from concordant cancer in only the parent, at 20/21 sites from a sibling proband and at 12/12 sites from a parent and sibling proband. The highest SIRs by parent were for Hodgkin's disease (4.88) and testicular (4.26), non‐medullary thyroid (3.26), ovarian (3.15) and esophageal (3.14) cancer and for multiple myeloma (3.33). When a sibling was affected, even prostate, renal, squamous cell skin, endocrine, gastric and lung cancer and leukemia showed SIRs in excess of 3.00. The highest cumulative risks were found for familial breast (5.5%) and prostate (4.2%) cancers. We identified reliable familial risks for 24 common neoplasms, most of which lack guidelines for clinical counseling or action level. If, for example, a familial SIR of 2.2 would be use as an action level, counseling would be needed for most cancers at some diagnostic age groups. The present data provide the basis for clinical counseling. © 2003 Wiley‐Liss, Inc.
This paper references
Tumors of the digestive system. WHO classification of tumors
S Hamilton (2000)
10.1054/bjoc.2001.1811
Birth order, family size, and the risk of cancer in young and middle-aged adults
K. Hemminki (2001)
10.1200/JCO.2002.05.006
Family history and prostate cancer screening with prostate-specific antigen.
T. Mäkinen (2002)
10.1038/ng879
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
H. Meijers-Heijboer (2002)
10.1002/ijc.1626
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population
A. Meindl (2002)
10.1001/ARCHDERM.135.3.261
Genetic and environmental influences in the development of multiple primary melanoma.
A. Burden (1999)
10.1038/72877
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours
Elizabeth A. Rapley (2000)
10.1007/BF02053699
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
H. Vasen (1991)
10.1136/jmg.36.11.801
Genetic susceptibility to non-polyposis colorectal cancer
H. Lynch (1999)
10.1080/02841860152619214
The nation-wide Swedish family-cancer database--updated structure and familial rates.
K. Hemminki (2001)
10.1002/(SICI)1097-0215(19990909)82:6<775::AID-IJC1>3.0.CO;2-V
Familial risks in cervical cancer: Is there a hereditary component?
K. Hemminki (1999)
10.1093/OXFORDJOURNALS.BMB.A072908
The inherited component of cancer.
D. Easton (1994)
10.1086/302287
Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.
M. Gibbs (1999)
10.1002/(SICI)1097-0215(19960529)66:5<627::AID-IJC8>3.0.CO;2-V
Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population‐based study
T. Westergaard (1996)
Kidney cancer from the nation-wide Swedish Family-Cancer Database: familial risks and association with second primary malignancies
K Czene (2002)
10.1093/JNCI/87.13.991
Risk of cancer in relatives of prostate cancer probands.
S. Isaacs (1995)
Family history and the risk of liver, gallbladder, and pancreatic cancer.
E. Fernandez (1994)
10.1038/bjc.1996.173
Familial testicular cancer in Norway and southern Sweden.
K. Heimdal (1996)
10.1038/ng853
Polygenic susceptibility to breast cancer and implications for prevention
P. Pharoah (2002)
10.1007/s004390000291
A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden
Y. Shugart (2000)
Familial and second gastric cancers: a nation wide epidemiologic study from Sweden
K Hemminki (2002)
10.1016/S0959-8049(01)00172-1
Familial testicular cancer and second primary cancers in testicular cancer patients by histological type.
C. Dong (2001)
10.1097/00008390-199608000-00006
Accuracy of case‐reported family history of melanoma in Queensland, Australia
J. Aitken (1996)
10.1054/bjoc.2000.1585
Sibling risks in cancer: clues to recessive or X-linked genes?
K. Hemminki (2001)
10.1002/cncr.10322
Familial and second gastric carcinomas
K. Hemminki (2002)
Risk of cancer among relatives of patients with glioma.
B. O'Neill (2002)
10.1007/s00439-002-0902-4
The future of association studies of common cancers
R. Houlston (2003)
10.1038/35042049
Use of population isolates for mapping complex traits
L. Peltonen (2000)
10.1054/bjoc.2000.1718
Familial colorectal adenocarcinoma and hereditary nonpolyposis colorectal cancer: a nationwide epidemiological study from Sweden
K. Hemminki (2001)
10.1002/ijc.1533
Familial colorectal adenocarcinoma from the Swedish family‐cancer database
K. Hemminki (2001)
10.4135/9781483346328.n66
Genetic testing.
W. Burke (2002)
10.1038/NG1002-233
Risk for familial breast cancer increases with age
K. Hemminki (2002)
10.1093/OXFORDJOURNALS.AJE.A009259
Comparison of self-reported and database-linked family history of cancer data in a case-control study.
R. Kerber (1997)
10.1002/(SICI)1097-0215(19961115)68:4<428::AID-IJC5>3.0.CO;2-2
Familial aggregation of colorectal cancer in the general population
B. Carstensen (1996)
10.1016/S0090-4295(01)01598-9
Accuracy of family history of cancer as reported by men with prostate cancer.
T. King (2002)
10.1056/NEJM199502163320701
Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease.
T. Mack (1995)
10.1016/S0169-5002(02)00535-4
Familial and second lung cancers: a nation-wide epidemiologic study from Sweden.
X. Li (2003)
10.1002/JSO.1035
Statistical methods in cancer research
P. Simpson (2001)
Underreporting of family history of colon cancer: correlates and implications.
K. Glanz (1999)
Dissecting human diseases in the postgenomic era
L Peltonen (2001)
[Where is the National Board of Health and Welfare?].
C. R. Torp (2003)
10.1093/JNCI/86.21.1600
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
D. Goldgar (1994)
10.1056/NEJM200007133430201
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
P. Lichtenstein (2000)
10.1056/NEJMRA012240
Genomic medicine--a primer.
A. Guttmacher (2002)
10.1093/JNCI/94.12.894
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D. Bishop (2002)
Attributable risks of familial cancer from the Family-Cancer Database.
K. Hemminki (2002)
10.1126/SCIENCE.278.5340.1050
Genetic testing for cancer risk.
B. Ponder (1997)
10.3109/10428190109064598
Apparent Anticipation and Heterogeneous Transmission Patterns in Familial Hodgkin's and Non-Hodgkin's Lymphoma: Report from a Study Based on Swedish Cancer Database
Y. Shugart (2001)
10.1126/SCIENCE.291.5507.1224
Dissecting Human Disease in the Postgenomic Era
L. Peltonen (2001)
10.1002/1097-0215(200102)9999:9999<::AID-IJC1147>3.0.CO;2-C
Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families
C. Dong (2001)
10.1038/sj.bjc.6600302
Cancer risks among long-standing spouses
K. Hemminki (2002)
10.7326/0003-4819-129-9-199811010-00045
The Genetic Basis of Human Cancer
C. Rubin (1998)
10.1046/J.1523-1755.2002.00304.X
Kidney cancer in the Swedish Family Cancer Database: familial risks and second primary malignancies.
K. Czene (2002)
10.1046/J.1523-1747.2003.12041.X
Familial and attributable risks in cutaneous melanoma: effects of proband and age.
K. Hemminki (2003)
10.1038/79866
How many diseases does it take to map a gene with SNPs?
K. Weiss (2000)
10.1016/S0022-5347(05)64924-5
American Cancer Society guidelines for the early detection of cancer.
P. Walsh (2001)
10.1002/ijc.10863
Familial and second primary pancreatic cancers: A nationwide epidemiologic study from Sweden
K. Hemminki (2003)
Comparison of self-reported and databaselinked family history of cancer data in a case-control study
R Kerber (1997)
Hereditary cancer in adults.
H. Lynch (1995)
10.1016/S0027-5107(00)00162-7
Genetic epidemiology of multistage carcinogenesis.
K. Hemminki (2001)
10.1002/ijc.10441
Cancer risks in twins: Results from the Swedish family‐cancer database
K. Hemminki (2002)
10.1016/S0959-8049(02)00462-8
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
M. V. Doeberitz (2002)
10.1002/1098-2272(200102)20:2<247::AID-GEPI7>3.0.CO;2-U
Cancer risks to spouses and offspring in the family‐cancer database
K. Hemminki (2001)
Familial and second
X Li (1999)
10.1002/ijc.10764
Familial risk of cancer by site and histopathology
K. Hemminki (2003)
The international 113 DATABASE collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC)
H Vasen (1991)
10.1002/ijc.10172
Familial and second esophageal cancers: A nation‐wide epidemiologic study from Sweden
K. Hemminki (2002)
10.1016/S0959-8049(00)00093-9
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?
H. Eerola (2000)
10.1016/s0959-8049(02)00462-8
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
M. von Knebel Doeberitz (2002)



This paper is referenced by
Familial risks for cancer with reference to lung cancer
X. Li (2004)
10.1007/s00345-003-0375-7
Familial risk of urological cancers: data for clinical counseling
K. Hemminki (2004)
10.1371/journal.pone.0027130
An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis
Michał Kiciński (2011)
10.1007/978-0-387-72114-9_2
Molecular genetics of lung and pleural neoplasms
P. Cagle (2008)
10.1093/AJE/KWJ361
Non-Hodgkin's lymphoma and family history of hematologic malignancy.
F. Mensah (2007)
10.1111/J.1365-2605.2005.00599.X
Familial risks in testicular cancer as aetiological clues.
K. Hemminki (2006)
10.1097/01.gim.0000250506.15979.0c
Familial testicular cancer: Interest in genetic testing among high-risk family members
J. Peters (2006)
10.1038/aja.2012.65
The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis.
J. Yang (2012)
10.1093/JNCI/DJJ361
Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.
O. Landgren (2006)
10.1038/s41375-018-0246-2
Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics
Alyssa I Clay-Gilmour (2018)
10.1038/nrg2009
Opinion: The balance between heritable and environmental aetiology of human disease
K. Hemminki (2006)
10.1016/J.RSSM.2008.06.001
Societal development and the shifting influence of the genome on status attainment
D. Adkins (2008)
Molecular classification of familial colorectal and endometrial carcinoma
M. Ollikainen (2007)
10.1093/jnci/djx237
Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case–Control Study
C. Martin (2018)
10.1515/CCLM.2010.114
Molecular biology and genetics in clinical chemistry and laboratory medicine
John B. Whitfield (2010)
10.4065/80.3.390
Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment.
A. Tefferi (2005)
10.1016/S1470-2045(07)70282-6
Familial concordance in cancer survival: a Swedish population-based study.
L. Lindström (2007)
10.1007/978-1-59745-224-3_22
Differentiation Agents and Epigenomic Therapies
Madeleine S. Q. Kortenhorst (2007)
10.1182/blood-2011-11-387324
Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
A. Greenberg (2012)
10.1016/j.canep.2012.05.002
Risk factors for multiple myeloma: a hospital-based case-control study in Northwest China.
Qixia Wang (2012)
10.1007/978-3-540-92810-2_6
Familial Nasopharyngeal Carcinoma
K. Loh (2010)
10.1111/j.1939-1676.2008.0255.x
Genetic and environmental risk indicators in canine non-Hodgkin's lymphomas: breed associations and geographic distribution of 608 cases diagnosed throughout France over 1 year.
M. Pastor (2009)
10.1375/183242706778025062
Familial risks for diseases of myoneural junction and muscle in siblings based on hospitalizations and deaths in sweden.
K. Hemminki (2006)
10.1016/j.critrevonc.2012.06.009
Squamous-cell carcinoma of the lungs: is it really so different?
M. Sereno (2012)
10.1093/JJCO/HYM048
Breast cancer in first-degree relatives and risk of lung cancer: assessment of the existence of gene sex interactions.
M. Tsuchiya (2007)
10.1002/ijc.30203
Validity of self‐reported family history of cancer: A systematic literature review on selected cancers
J. Fiederling (2016)
10.1016/j.eururo.2014.12.031
Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.
E. Kharazmi (2015)
10.1182/blood.2019001362
Analysis of 153,115 patients with hematological malignancies refines the spectrum of familial risk.
A. Sud (2019)
10.1093/annonc/mdn527
Age of onset in familial cancer.
A. Brandt (2008)
10.1016/J.MRFMMM.2005.05.008
Relationships between familial risks of cancer and the effects of heritable genes and their SNP variants.
K. Hemminki (2005)
10.4236/OJI.2011.12004
Functions of hereditary immunity and xenogamy in cancer origin and pandemic spread
S. Rumyantsev (2011)
EFFECTS OF KINSHIP AND TIMING IN FAMILIAL CANCER
M. Lee (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar